You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Comprehensive clinical, radiological, pathological and biochemical analysis required to differentiate VV1 sporadic Creutzfeldt-Jakob disease from suspected variant CJD

Article info

Article menu

Download PDFPDF

Short report
Comprehensive clinical, radiological, pathological and biochemical analysis required to differentiate VV1 sporadic Creutzfeldt-Jakob disease from suspected variant CJD

Authors

  • Sarah Holper Department of Neurosciences, The Royal Melbourne Hospital, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Victoria Lewis Australian National CJD Registry, The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, AustraliaDepartment of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Robb Wesselingh Department of Neurosciences, Alfred Hospital, Melbourne, Victoria, AustraliaMonash University Central Clinical School, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Frank Gaillard Faculty of Medicine Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, AustraliaDepartment of Radiology, The Royal Melbourne Hospital, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Steven J Collins Australian National CJD Registry, The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, AustraliaDepartment of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Helmut Butzkueven Department of Neurosciences, Alfred Hospital, Melbourne, Victoria, AustraliaMonash University Central Clinical School, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sarah Holper; sarah.holper{at}mh.org.au
View Full Text

Citation

Holper S, Lewis V, Wesselingh R, et al
Comprehensive clinical, radiological, pathological and biochemical analysis required to differentiate VV1 sporadic Creutzfeldt-Jakob disease from suspected variant CJD
BMJ Neurology Open 2022;4:e000299. doi: 10.1136/bmjno-2022-000299

Publication history

  • Accepted March 31, 2022
  • First published April 19, 2022.
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.